Related Experiment Video
Updated: Apr 23, 2026
08:29
SUMO-Binding Entities SUBEs as Tools for the Enrichment, Isolation, Identification, and Characterization of the SUMO Proteome in Liver Cancer
Published on: November 1, 2019
7.5K
SUMO proteomics to decipher the SUMO-modified proteome regulated by various diseases
1Molecular Neurobiology Laboratory, Department of Anesthesiology, Duke University Medical Center, Durham, NC, USA.
Proteomics
|September 20, 2014
Summary
Small ubiquitin-like modifier (SUMO) conjugation impacts protein function and is linked to numerous diseases. New mouse models and enrichment strategies aid in studying SUMOylation for disease target identification.
Area of Science:
- Biochemistry
- Molecular Biology
- Proteomics
Background:
- Small ubiquitin-like modifier (SUMO) conjugation is a crucial posttranslational modification affecting protein activity, stability, and function.
- SUMOylation plays a role in nearly all cellular pathways and is implicated in diseases like cancer, heart failure, and neurodegenerative disorders.
Purpose of the Study:
- To characterize the SUMO-modified proteome in various diseases.
- To develop and utilize advanced analytical tools for studying SUMOylation in complex biological samples.
Main Methods:
- Enrichment strategies for low-abundance SUMOylated proteins, including epitope-tagged SUMO expression and antibody-based immunoprecipitation.
- Affinity purification using SUMO interaction motifs to isolate polySUMOylated proteins.
- Characterization of novel mouse models expressing tagged SUMO isoforms for proteomic analysis.
Main Results:
- Development of effective methods to enrich SUMOylated proteins from complex cell and tissue extracts.
- Successful generation and characterization of mouse models for studying SUMOylation in vivo.
- Advancement of tools for comprehensive SUMO proteomics analysis.
Conclusions:
- New analytical tools, including mouse models, significantly improve the ability to study SUMOylation.
- These advancements will facilitate the deciphering of disease-associated SUMO-modified proteomes.
- This research aims to identify novel therapeutic and preventive targets for various human diseases.
Related Concept Videos
01:33Proteomics
7.4K
A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
7.4K
02:04Covalently Linked Protein Regulators
8.2K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
8.2K
01:13The Proteasome
1.6K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.6K